TMO vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$400.49
-1.1% upside to fair value
Grade D
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
TSLA |
| Current Price |
$464.61 |
$400.49 |
| Fair Value Estimate |
$498.27 |
$396.15 |
| Upside to Fair Value |
+7.2%
|
-1.1%
|
| Market Cap |
$172.7B |
$1,504.1B |
| Forward P/E |
25.2x
|
334.1x
|
| EV / EBITDA |
19.1x
|
124.0x
|
| Price / Sales |
3.8x
|
15.4x
|
| Price / FCF |
25.6x
|
214.9x
|
| Revenue Growth YoY |
+6.2%
|
+15.8%
|
| Gross Margin |
39.4%
|
19.1%
|
| Operating Margin |
17.8%
|
5.0%
|
| Return on Equity |
13.3%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.91%
|
0.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Tesla, Inc. is a leading global electric vehicle manufacturer and energy solutions provider, led by CEO Elon Musk since 2008. The company maintains a strong position in the EV market with a unique fast-charging and software ecosystem, although its EV market share is declining amid intensifying competition. Tesla's business quality is medium due to its narrowing moat and modest profitability, with…
Accumulation Zones
| Metric |
TMO |
TSLA |
| Zone Low |
$373.70 |
$297.11 |
| Zone High |
$423.53 |
$336.73 |
| In Buy Zone? |
No
|
No
|